AAWH Sales Down 10%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 07 2025
0mins
Should l Buy ?
Source: NASDAQ.COM
Financial Performance: Ascend Wellness reported a GAAP net loss per share of ($0.12) and revenue of $127.3 million for Q2 2025, missing analyst forecasts and reflecting a 10% year-over-year decline, despite improvements in adjusted EBITDA margin and positive operating cash flow for ten consecutive quarters.
Operational Developments: The company expanded its retail presence to 44 locations and launched numerous new products, including a successful line targeting experienced users; however, overall revenue growth remained stagnant due to industry pricing pressures and challenges in wholesale sales.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
